Assessment of decellularized pericardial extracellular matrix and poly(propylene fumarate) biohybrid for small-diameter vascular graft applications
Source abstract
Abstract
Autologous grafts are the current gold standard of care for coronary artery bypass graft surgeries, but are limited by availability and plagued by high failure rates. Similarly, tissue engineering approaches to small diameter vascular grafts using naturally derived and synthetic materials fall short, largely due to inappropriate mechanical properties. Alternatively, decellularized extracellular matrix from tissue is biocompatible and has comparable strength to vessels, while poly(propylene fumarate) (PPF) has shown promising results for vascular grafts. This study investigates the integration of decellularized pericardial extracellular matrix (dECM) and PPF to create a biohybrid scaffold (dECM+PPF) suitable for use as a small diameter vascular graft. Our method to decellularize the ECM was efficient at removing DNA content and donor variability, while preserving protein composition. PPF was characterized and added to dECM, where it acted to preserve dECM against degradative effects of collagenase without disturbing the material's overall mechanics. A transport study showed that diffusion occurs across dECM+PPF without any effect from collagenase. The modulus of dECM+PPF matched that of human coronary arteries and saphenous veins. dECM+PPF demonstrated ample circumferential stress, burst pressure, and suture retention strength to survive in vivo. An in vivo study showed re-endothelialization and tissue growth. Overall, the dECM+PPF biohybrid presents a robust solution to overcome the limitations of the current methods of treatment for small diameter vascular grafts. STATEMENT OF SIGNIFICANCE: In creating a dECM+PPF biohybrid graft, we have observed phenomena that will have a lasting impact within the scientific community. First, we found that we can reduce donor variability through decellularization, a unique use of the decellularization process. Additionally, we coupled a natural material with a synthetic polymer to capitalize on the benefits of each: the cues provided to cells and the ability to easily tune material properties, respectively. This principle can be applied to other materials in a variety of applications. Finally, we created an off-the-shelf alternative to autologous grafts with a newly developed material that has yet to be utilized in any scaffolds. Furthermore, bovine pericardium has not been investigated as a small diameter vascular graft.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Cardiac Structural Anomalies and Repair
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (71)
Show source-provided references
1. Secondary prevention after coronary artery bypass graft surgery10.1161/CIR.0000000000000182 ↗
2. Coronary artery bypass graft surgery: The past, present, and future of myocardial revascularisation
3. Current strategies for the manufacture of small size tissue engineering vascular grafts
4. Evaluation of synthetic vascular grafts in a mouse carotid grafting model10.1371/journal.pone.0174773 ↗
5. Biomaterials and tissue engineering.
6. Remodeling of an acellular collagen graff into a physiologically responsive neovessel10.1038/15062 ↗
7. Tissue engineering of small-diameter vascular grafts by endothelial progenitor cells seeding heparin-coated decellularized scaffolds10.1002/jbm.b.31928 ↗
8. The tissue-engineered vascular graft—past, present, and future10.1089/ten.teb.2015.0100 ↗
9. The Johns Hopkins Heart and Vascular Institute. How to Fight Bypass Failure. Cardiovascular report https://www.hopkinsmedicine.org/news/publications/cardiovascular_report/cardiovascular_report_winter_2011/how_to_fight_bypass_failure (2011).
10. Scaffolds in vascular regeneration: current status
11. Small-diameter artificial arteries engineered in vitro10.1161/01.RES.0000196867.12470.84 ↗
12. Process-induced extracellular matrix alterations affect the mechanisms of soft tissue repair and regeneration10.1177/2041731413505305 ↗
13. In vivo performance of decellularized vascular grafts: a review article10.3390/ijms19072101 ↗
14. Mechanical behaviour of isolated pericardium: species, isotropy, strain rate and collagenase effect on pericardial tissue10.1016/0267-6605(87)90030-8 ↗
15. A comparative study on the mechanical properties of the healthy and varicose human saphenous vein under uniaxial loading10.3109/03091902.2015.1086030 ↗
16. Biomaterial applications in cardiovascular tissue repair and regeneration10.1586/erc.12.99 ↗
17. Bovine pericardial extracellular matrix niche modulates human aortic endothelial cell phenotype and function10.1038/s41598-019-53230-1 ↗
18. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery10.1016/j.biomaterials.2008.11.011 ↗
19. Biomaterials for vascular tissue engineering10.2217/rme.09.77 ↗
20. The use of antithrombotic therapies in reducing synthetic small-diameter vascular graft thrombosis10.1177/1538574411433299 ↗
21. Reinforced pericardium as a hybrid material for cardiovascular applications10.1089/ten.tea.2014.0516 ↗
22. Synthetic polymer coatings diminish chronic inflammation risk in large ECM-based materials10.1002/jbm.a.36564 ↗
23. 3D-printed biodegradable polymeric vascular grafts10.1002/adhm.201500725 ↗
24. A short discourse on vascular tissue engineering10.1038/s41536-017-0011-6 ↗
25. Synthesis of poly(propylene fumarate)10.1038/nprot.2009.24 ↗
26. Decellularized tissue-engineered blood vessel as an arterial conduit10.1073/pnas.1019506108 ↗
27. Pericardial tissue for cardiovascular application: an in-vitro evaluation of established and advanced production processes10.1007/s10856-018-6186-6 ↗
28. Current usage and future directions for the bovine pericardial patch10.1016/j.avsg.2010.11.007 ↗
29. Self-made pericardial tube graft: a new surgical concept for treatment of graft infections after thoracic and abdominal aortic procedures10.1016/j.athoracsur.2011.06.073 ↗
30. The use of bovine pericardial patch for vascular reconstruction in infected fields for transplant recipients10.1016/j.jvscit.2016.10.006 ↗
31. Aortic valve replacement with bovine pericardial tissue valve in children and young adults10.1161/CIRCULATIONAHA.118.037187 ↗
32. Pericardial covered stent for coronary perforations
33. Novel use of a pericardium-covered stent graft to treat bulky coronary artery thrombus
34. Light and Electron Microscopic Analyses of Autologous Pericardial Tissue Used as a Small-Diameter Arterial Graft in Dogs10.1046/j.1525-1594.2002.6747_3.x ↗
35. Controlled delivery of tissue inductive factors in a cardiovascular hybrid biomaterial scaffold10.1021/acsbiomaterials.6b00460 ↗
36. Decellularization and delipidation protocols of bovine bone and pericardium for bone grafting and guided bone regeneration procedures10.1371/journal.pone.0132344 ↗
37. Decellularization of pericardial tissue and its impact on tensile viscoelasticity and glycosaminoglycan content10.1016/j.actbio.2010.11.017 ↗
38. Decellularization of tissues and organs10.1016/j.biomaterials.2006.02.014 ↗
39. Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction10.1002/jbm.820280602 ↗
40. Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model10.1073/pnas.1213228110 ↗
41. In vivo response of acellular porcine pericardial for tissue engineered transcatheter aortic valves10.1038/s41598-018-37550-2 ↗
42. An overview of tissue and whole organ decellularization processes10.1016/j.biomaterials.2011.01.057 ↗
43. Molecular assessment of collagen denaturation in decellularized tissues using a collagen hybridizing peptide10.1016/j.actbio.2017.01.079 ↗
44. Photoinitiated cross-linking of the biodegradable polyester poly(propylene fumarate). part I. determination of network structure10.1021/bm030028d ↗
45. Biocompatibility and degradation of tendon-derived scaffolds10.1093/rb/rbv023 ↗
46. Development of keratin-based membranes for potential use in skin repair10.1016/j.actbio.2018.10.025 ↗
47. Vascular smooth muscle cells on hyaluronic acid: culture and mechanical characterization of an engineered vascular construct10.1089/1076327041348347 ↗
48. Establishment of a rat and guinea pig aortic interposition graft model reveals model specific patterns of intimal hyperplasia10.1016/j.jvs.2015.09.052 ↗
49. Development and assessment of a biodegradable solvent cast polyester fabric small-diameter vascular graft10.1002/jbm.a.34872 ↗
50. Novel utilization of serum in tissue decellularization10.1089/ten.tec.2009.0120 ↗
51. Mechanical loading of bovine pericardium accelerates enzymatic degradation10.1016/S0142-9612(99)00013-7 ↗
52. Evaluation of the in vitro cytotoxicity of crosslinked biomaterials10.1021/bm301962f ↗
53. Evaluating changes in structure and cytotoxicity during in vitro degradation of three-dimensional printed scaffolds10.1089/ten.tea.2014.0495 ↗
54. Effect of chemical and physical properties on the in vitro degradation of 3D printed high resolution poly(propylene fumarate) scaffolds10.1021/acs.biomac.7b00146 ↗
55. Early osteogenic signal expression of rat bone marrow stromal cells is influenced by both hydroxyapatite nanoparticle content and initial cell seeding density in biodegradable nanocomposite scaffolds10.1016/j.actbio.2010.11.007 ↗
56. Influence of crosslinking on the stiffness and degradation of dermis-derived hydrogels10.1002/jbm.a.34602 ↗
57. Relationship between cross-linking reaction time and anisotropic mechanical behavior of enzyme crystals10.1021/acs.cgd.9b00232 ↗
58. Fabrication and in vitro degradation of porous fumarate-based polymer/alumoxane nanocomposite scaffolds for bone tissue engineering
59. Effect of polycaprolactone scaffold permeability on bone regeneration in vivo10.1089/ten.tea.2010.0560 ↗
60. Simultaneous measurement of beat-to-beat carotid diameter and pressure changes to assess arterial mechanical properties10.1161/HYPERTENSIONAHA.108.116509 ↗
61. Small coronary vessel pressure and diameter in an intact beating rabbit heart using fixed-position and free-motion techniques10.1161/01.RES.49.2.342 ↗
62. Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendations10.1007/s00508-016-0998-5 ↗
63. The J-Curve between blood pressure and coronary artery disease or essential hypertension10.1016/j.jacc.2009.05.073 ↗
64. Measurement of the uniaxial mechanical properties of healthy and atherosclerotic human coronary arteries10.1016/j.msec.2013.02.016 ↗
65. Changes in the mechanical properties, biochemical contents and wall structure of the human coronary arteries with age and sex10.1016/S1350-4533(98)00050-2 ↗
66. The elasticity of canine and human coronary arteries with reference to postmortem changes10.1161/01.RES.45.5.588 ↗
67. Long-term preservation of human saphenous vein by green tea polyphenol under physiological conditions10.1089/ten.2005.11.1054 ↗
68. In vitro mechanical property evaluation of chitosan-based hydrogels intended for vascular graft development10.1007/s12265-017-9763-z ↗
69. Mechanical properties of porcine and human arteries: Implications for coronary anastomotic connectors10.1016/S0003-4975(03)00263-7 ↗
70. The role of vascular smooth muscle cells in the physiology and pathophysiology of blood vessels
71. Saphenous vein graft failure after coronary artery bypass surgery10.1097/SLA.0b013e318288c38d ↗